Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 996 of 5804
-
Sponge treatment may fix dangerous gut leaks without more surgery
Disease control Recruiting nowThis study is intended to evaluate the safety and effectiveness of Sponge-based Endoscopic Vacuum Therapy (EVT) using Endo-SPONGE for the treatment of Anastomotic Leaks (AL) or Hartmann's stump leakages following colorectal surgery in a prospective multi-center study.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New drug could change kidney transplants forever
Disease control Not yet recruitingThis study will evaluate the safety and efficacy of VEL-101 compared with tacrolimus in patients undergoing kidney transplantation.
Phase: PHASE2 • Sponsor: Veloxis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Robot arm training could boost stroke recovery
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate how manual dominance influences the effectiveness of bilateral robotic treatment in right-handed patients with chronic stroke. Researchers will compare the outcome of a bilateral robotic treatment for the upper limbs in left vs righ…
Phase: NA • Sponsor: University of Pisa • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThe goal of this clinical trial is to compare antiviral treatment strategies for cytomegalovirus (CMV) anterior uveitis - a viral infection causing inflammation inside the front of the eye - in immunocompetent adults aged 18 years and older. The main questions it aims to answer a…
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Mouth spray may stop radiation burns in cancer patients
Prevention Not yet recruitingThis is a prospective, open-label, randomized, controlled, multicenter phase II study evaluating the efficacy and safety of Kangfu Spray for the prevention of radiation-induced oral mucositis in patients with histologically confirmed oral malignancies receiving intensity-modulate…
Phase: NA • Sponsor: YE ZHANG • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
Engineered t cells take on brain tumors in first human test
Disease control Not yet recruitingThis is a Phase I Study evaluating the safety and feasibility of IL-8 receptor-modified patient-derived activated CD70 CAR T cells in adult patients with brain metastases from primary cancer, with either newly diagnosed lesions or recurrent or progressive disease after prior ther…
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could your carpal tunnel surgery reveal a silent heart condition?
Diagnosis Not yet recruitingCardiac amyloidosis is a condition where abnormal protein deposits build up in the heart, making it stiff and causing it to work less effectively. One common type is caused by a normal blood protein called transthyretin (TTR), which can become unstable and form these deposits. Wh…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Diagnosis
Last updated Jun 27, 2026 12:32 UTC
-
New diabetes shot could cut injections to once a month
Disease control Not yet recruitingSemaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is an approved and well-established therapy for type 2 diabetes mellitus (T2DM), providing both robust glycemic control and weight reduction. Semaglutide Depot, is a long-acting formulation of semaglutide, designed …
Phase: PHASE1, PHASE2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Skull-Implanted device aims to lift severe depression
Disease control Not yet recruitingThe objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).
Phase: NA • Sponsor: Motif Neurotech, Inc. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Fat grafting vs. flap surgery: which is better for breast reconstruction after radiation?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether autologous fat transfer (AFT) is as effective and safe as Deep Inferior Epigastric Perforator (DIEP) flap breast reconstruction in irradiated breast cancer patients following mastectomy. It will also evaluate patient satisfactio…
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New study aims to unlock secrets of penetrating brain injuries
Knowledge-focused Not yet recruitingThe purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specifi…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
New radiation approach aims to boost lung cancer treatment in poor responders
Disease control Not yet recruitingLattice radiation therapy (LRT) is a spatially fractionated thoracic radiotherapy technique that creates alternating high- and low-dose regions within primary lung tumors and metastatic lymph nodes to strengthen local tumor suppression and reduce radiation injury to normal thorac…
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Simple CT scan could reveal hidden heart risks in HIV patients
Knowledge-focused Not yet recruitingThe risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated ather…
Sponsor: Instituto Mexicano del Seguro Social • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Not yet recruitingThis study is an open-label, multicenter, non-randomized Phase I clinical study with dose-escalation and expansion cohorts, designed to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patient…
Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Next-Generation polio vaccine enters human testing
⭐️ VACCINE ⭐️ Not yet recruitingThe primary purpose of this study is to test a new experimental recombinant Poliomyelitis vaccine (rPV) in comparison to the commercially available inactivated poliovirus vaccine. The design of the study is double-blinded, randomised and active controlled. The active controlled p…
Phase: PHASE1 • Sponsor: Serum Institute of India Pvt. Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated Jul 12, 2026 00:00 UTC
-
New study investigates hidden heart risks in cystic fibrosis patients on modern drugs
Knowledge-focused Not yet recruitingCystic fibrosis (CF) is a disease that affects over 11,000 people in the UK. It is a genetic condition that affects many organs including the lungs, pancreas, kidneys and liver. New drugs called "modulators" have meant people with CF are now living much longer. Until recently, he…
Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Supplements may boost footballers' mental endurance and decision-making
Disease control Not yet recruitingThis randomized, double-blind, placebo-controlled, parallel-group trial will evaluate the effects of 14 days of taurine-caffeine supplementation with or without phosphatidylserine on neurocognitive fatigue resistance, visual search efficiency, and football-specific tactical decis…
Phase: NA • Sponsor: Vizja University in Warsaw • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Simple change in probe care could prevent painful skin injuries in intensive care
Disease control ENROLLING_BY_INVITATIONPatients admitted to intensive care units (ICUs) are at increased risk of medical device-related pressure injuries (MDRPIs) due to the prolonged use of monitoring devices. Pulse oximeter probes are routinely used for continuous monitoring of oxygen saturation and pulse rate and m…
Phase: NA • Sponsor: Emine Arici Parlak • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can acupuncture help women regain bladder control after hysterectomy?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if acupuncture works to treat postoperative urinary retention in patients who have undergone radical hysterectomy for cervical cancer. The main question it aims to answer is: Does acupuncture lower the volume of post-void residual in p…
Phase: NA • Sponsor: Obstetrics & Gynecology Hospital of Fudan University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Can a two-drug combo better tame prostate trouble?
Symptom relief Recruiting nowThis study aims to evaluate the short-term impact and clinical outcomes of tamsulosin monotherapy versus combination therapy with tamsulosin plus tadalafil (2.5 mg vs. 5 mg) on lower urinary tract symptoms (LUTS) severity and patient quality of life in men with benign prostatic h…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC